Drug details

Nexavar (sorafenib)

type of Antineoplastic Tyrosine Kinase Inhibitors, Antineoplastics, VEGF Inhibitor

Nexavar (sorafenib) is a cancer (chemotherapeutic) medication used to treat a type of kidney cancer called advanced renal cell carcinoma. Nexavar is also used to treat liver cancer.

This drug may have the following side effects:

• nausea,
• vomiting,
• diarrhea,
• loss of appetite,
• stomach pain,
• dry mouth,
• itching or skin rash,
• acne,
• dry skin,
• hoarseness, or
• patchy hair loss/thinning,
• tiredness.

The following drugs are related to Nexavar, either as a replacement or used together:

• Afinitor (everolimus tablets)
• Proleukin (aldesleukin for injection)
• Caprelsa (vandetanib)
• Fotivda (tivozanib capsules)
• Lytgobi (futibatinib tablets)
• Sancuso (granisetron transdermal system)
• Hepzato (melphalan for injection)
• Imjudo (tremelimumab-actl injection)
• Lenvima (lenvatinib capsules)